Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia

Archives of Ophthalmology

Volumn 121, Issue 7, 2003, Pages 1064-1065

  Colucciello, Michael ^a  

^a South Jersey Eye Physicians   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; HYBRID PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ABDUCENS NERVE PARALYSIS; ADULT; ARTICLE; BLOOD PRESSURE; BRAIN PSEUDOTUMOR; CANCER REGRESSION; CASE REPORT; CHROMOSOME TRANSLOCATION 15; CLINICAL FEATURE; DIPLOPIA; EYE FUNDUS; GENE FUNCTION; HEADACHE; HUMAN; INTRACRANIAL PRESSURE; LUMBAR PUNCTURE; MALE; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; VISUAL ACUITY;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; INTRACRANIAL PRESSURE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; PAPILLEDEMA; PSEUDOTUMOR CEREBRI; RETINAL HEMORRHAGE; TRETINOIN;

EID: 0037925516     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.7.1064     Document Type: Article

References (5)

1. Frankel SR, Eardley A, Heller G, et al. All-trans retinoic acid for acute promyelocytic leukemia: results of the New York Study. Ann Intern Med. 1994;120:278-286.
2. Visani G, Bontempo G, Manfroi S, Pazzaglia A, D'Alessandro R, Tura S. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association. Haematologica. 1996;81:152-154.
3. Visani G, Manfroi S, Tosi P, Martinelli G. Alltrans-retinoic acid and pseudotumor cerebri. Leuk Lymphoma. 1996;23:437-442.
4. Sano F, Tsuji K, Kunika N, et al. Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Intern Med. 1998;37:546-549.
5. Schroeter T, Lanvers C, Herding H, Suttorp M. Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia. Med Pediatr Oncol. 2000;34:284-286.